IGF1R and osteosarcoma: Systemic evaluation of on-target toxicity by IGF1R CAR T cells in canine sarcoma models will be tested as IGF1R CAR-derived 1H7 mab cross reacted with canine osteosarcoma lines (Park et al., unpublished data).